This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Daiichi Sankyo Company, Limited, Exelixis, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 462 
1 out of 177 
Years Active: 2014
Title: Masatoshi Honzumi: Innovator in Cardiovascular Treatment
Introduction
Masatoshi Honzumi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various cardiovascular diseases.
Latest Patents
Honzumi holds a patent for 1-phenylpyrrole derivatives. This invention comprises a compound designed for the prevention and/or treatment of cardiovascular diseases, nephropathy, fibrosis, primary aldosteronism, or edema. The compound is characterized by a specific general formula that includes various functional groups, making it a versatile option for therapeutic applications.
Career Highlights
Throughout his career, Masatoshi Honzumi has worked with prominent companies in the pharmaceutical industry. He has been associated with Exelixis, Inc. and Daiichi Sankyo Company, Limited, where he has contributed to innovative research and development efforts.
Collaborations
Honzumi has collaborated with esteemed colleagues, including John M. Nuss and Matthew A. Williams. These partnerships have further enhanced his research capabilities and have led to advancements in the field.
Conclusion
Masatoshi Honzumi's work in developing compounds for cardiovascular treatment showcases his dedication to improving healthcare outcomes. His innovative spirit and collaborative efforts continue to make a significant impact in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile